Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy.
about
New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunityLymphocyte subset reconstitution in pediatric liver recipients induced with steroid-free rabbit anti-human thymocyte globulin.Exploiting novel molecular targets in gastrointestinal cancers.Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors.Crossing the bridge: large animal models in translational transplantation research.Associations of ABCB1 3435C>T and IL-10-1082G>A polymorphisms with long-term sirolimus dose requirements in renal transplant patients.Strategies to prevent chronic allograft nephropathy in kidney transplantation: focus on calcineurin inhibitors.Emerging trends in infections among renal transplant recipients.Strategies for minimizing immunosuppression in kidney transplantation.Clinical application of sirolimus in renal transplantation: an update.Memory T cells and their exhaustive differentiation in allograft tolerance and rejection.Transplant tolerance in non-human primates: progress, current challenges and unmet needs.From current immunosuppressive strategies to clinical tolerance of allografts.Paradoxical aspects of rapamycin immunobiology in transplantationHost CD4+CD25+ T cells can expand and comprise a major component of the Treg compartment after experimental HCTElevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit anti-human thymocyte globulin.The mammalian target of rapamycin: linking T cell differentiation, function, and metabolismRegulation of immune responses by mTOR.The role of Thymoglobulin induction in kidney transplantation: an update.Lymphodepletional strategies in transplantation.Recollective homeostasis and the immune consequences of peritransplant depletional induction therapy.Current challenges and future directions for liver transplantation.Alemtuzumab as Antirejection Therapy: T Cell Repopulation and Cytokine Responsiveness.Calcineurin inhibitor-free immunosuppression in dual kidney transplantation from elderly donors.Kidney transplantation under a tolerogenic regimen of recipient pretreatment and low-dose postoperative immunosuppression with subsequent weaning.Induction sirolimus and delayed graft function after deceased donor kidney transplantation in the United States.Enhanced donor-specific alloreactivity occurs independently of immunosuppression in children with early liver rejection.Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.IDEC-131 (anti-CD154), sirolimus and donor-specific transfusion facilitate operational tolerance in non-human primates.Steroid avoidance versus steroid withdrawal after simultaneous pancreas-kidney transplantation.A randomized trial of alemtuzumab vs. anti-thymocyte globulin induction in renal and pancreas transplantation.IL-21 Biased Alemtuzumab Induced Chronic Antibody-Mediated Rejection Is Reversed by LFA-1 Costimulation BlockadeDrug-Induced Hematological Cytopenia in Kidney Transplantation and the Challenges It Poses for Kidney Transplant Physicians
P2860
Q26823090-E156644E-2B2A-463F-8BB0-5149CC1367CFQ34147538-2DA22C72-E2B2-433F-90FA-26F5F952D1B3Q34382777-49451091-EFD2-4A0C-B0A4-48F4C5EAA335Q34412887-BCC5B25C-F61D-43F2-BD34-94A68EC675B4Q35583529-56C92CB8-8EB7-4B26-918C-BCD78EAE44E3Q35613163-3F10D6B6-D783-4054-8649-4949B7B94BF1Q35841386-ED60C623-5AB2-4397-9BCB-14BFFFABC1AFQ35917332-F99E5188-DC7D-4936-AF5E-1FA8EC6FA875Q35990853-99C4D9E6-EC42-46D7-938F-EDD0808D8F09Q36054093-B388D16F-587A-42A0-8E3C-1CFD101E6F5AQ36095846-7B70359A-EB41-40AC-BB5B-D997C41A93FEQ36447590-25968E54-0D09-41AD-B0D9-60EAE3F21AB4Q36689232-515E3563-2872-46C7-BAE6-70319FA3A309Q36937264-05075FF1-240B-432D-91F2-3EABD36EFE95Q37066280-325AF63B-F6DB-460B-9CE7-6959D3470D3AQ37317873-D0882D84-66DF-4C15-A66F-3BD5AF1F6101Q37792556-4513E59F-2243-48C4-A468-119A26799DD6Q37963950-5476C46E-E4EF-4FC7-98F0-4D4200CA9651Q38051718-C9C206E0-83E5-4768-913D-B2DD7D369FE2Q38118743-71C82CBE-8900-4964-BB2F-0E9B650E0752Q38187176-E4E15B6F-F50A-4A58-8380-4DE09B234732Q38820685-3CDC29D6-2508-49D4-88AF-AA09DBD92D9BQ39513891-D9DC3050-856F-49BE-A148-F1C4D366821BQ43823533-5B1DB807-B465-44E1-B931-59F82CAD607AQ44609121-43658035-E70E-4FC6-8C10-A51DA05388A6Q44981183-8A8BFD1F-5CB7-47D3-A2B2-23BE6C8CE35EQ45214560-CADDCC55-E283-4E11-87D4-4F9027598F09Q46152226-F318C96B-0F17-41B7-9391-D85EB3140E5AQ46427141-1EE0B153-DE3D-4BBC-856D-BC3DA2C3210FQ46485554-5E9B2F25-4947-479B-B573-F358837EA951Q46793006-21EC00ED-D6C6-4587-9A2D-6CA05B3F033CQ58122073-A539FB12-7EE2-4644-ACF5-3BB9B1B2CE20Q58805821-6C08EB2B-A2F1-4FEC-88EA-6466D6E2F891
P2860
Kidney transplantation with rabbit antithymocyte globulin induction and sirolimus monotherapy.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Kidney transplantation with ra ...... ion and sirolimus monotherapy.
@en
Kidney transplantation with ra ...... ion and sirolimus monotherapy.
@nl
type
label
Kidney transplantation with ra ...... ion and sirolimus monotherapy.
@en
Kidney transplantation with ra ...... ion and sirolimus monotherapy.
@nl
prefLabel
Kidney transplantation with ra ...... ion and sirolimus monotherapy.
@en
Kidney transplantation with ra ...... ion and sirolimus monotherapy.
@nl
P2093
P1433
P1476
Kidney transplantation with ra ...... ion and sirolimus monotherapy.
@en
P2093
Allan D Kirk
Christine E Chamberlain
David M Harlan
Douglas A Hale
Linda C Cendales
Roslyn B Mannon
S John Swanson
Shirley M Polly
P304
P356
10.1016/S0140-6736(02)11606-0
P407
P577
2002-11-01T00:00:00Z